- Home
- LEXX vs GTIM Comparison
LEXX vs GTIM Comparison
Compare LEXX & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- GTIM
- Stock Information
- Founded
- LEXX 2004
- GTIM 1987
- Country
- LEXX Canada
- GTIM United States
- Employees
- LEXX N/A
- GTIM N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- GTIM Restaurants
- Sector
- LEXX Health Care
- GTIM Consumer Discretionary
- Exchange
- LEXX Nasdaq
- GTIM Nasdaq
- Market Cap
- LEXX 20.9M
- GTIM 17.0M
- IPO Year
- LEXX N/A
- GTIM 1990
- Fundamental
- Price
- LEXX $0.98
- GTIM $1.62
- Analyst Decision
- LEXX Strong Buy
- GTIM
- Analyst Count
- LEXX 1
- GTIM 0
- Target Price
- LEXX $7.00
- GTIM N/A
- AVG Volume (30 Days)
- LEXX 90.9K
- GTIM 22.0K
- Earning Date
- LEXX 07-11-2025
- GTIM 05-08-2025
- Dividend Yield
- LEXX N/A
- GTIM N/A
- EPS Growth
- LEXX N/A
- GTIM 65.30
- EPS
- LEXX N/A
- GTIM 0.09
- Revenue
- LEXX $525,923.00
- GTIM $144,322,000.00
- Revenue This Year
- LEXX $0.62
- GTIM N/A
- Revenue Next Year
- LEXX $14.19
- GTIM N/A
- P/E Ratio
- LEXX N/A
- GTIM $17.03
- Revenue Growth
- LEXX 29.95
- GTIM 4.14
- 52 Week Low
- LEXX $0.95
- GTIM $1.51
- 52 Week High
- LEXX $4.44
- GTIM $3.45
- Technical
- Relative Strength Index (RSI)
- LEXX 38.55
- GTIM 35.58
- Support Level
- LEXX $1.00
- GTIM $1.51
- Resistance Level
- LEXX $1.05
- GTIM $1.64
- Average True Range (ATR)
- LEXX 0.05
- GTIM 0.08
- MACD
- LEXX 0.01
- GTIM 0.01
- Stochastic Oscillator
- LEXX 28.80
- GTIM 13.51
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.